Capital World Investors - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 95 filers reported holding G1 THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.

Quarter-by-quarter ownership
Capital World Investors ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$1,401,000
-93.9%
84,400
-93.0%
0.00%
-100.0%
Q4 2018$23,114,000
-63.6%
1,207,000
-0.7%
0.01%
-60.0%
Q3 2018$63,532,000
+44.3%
1,215,000
+19.9%
0.02%
+66.7%
Q2 2018$44,025,000
+150.2%
1,013,000
+113.3%
0.01%
+125.0%
Q1 2018$17,599,000475,0000.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders